(Hypertension. 1999;33:256-260.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Laboratory Medicine, University of California, San Francisco, Calif (E.S.L., L.Z., Y.Y., J-M.W., N.W., N.Q., J.S.S., W.L.); Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Prague, Czech Republic (V.K., D.K., M.P.); Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic (V.K., V.Z., M.P.); and Department of Physiology, Wayne State University School of Medicine, Detroit, Mich (P.C.C., M.C.C.).
Correspondence to Elizabeth St. Lezin, MD, Department of Laboratory Medicine, UCSF/Mt. Zion Medical Center, 1600 Divisadero St, San Francisco, CA 94143-1613. E-mail stlezin{at}pangloss.ucsf.edu
AbstractLinkage studies in the spontaneously hypertensive rat (SHR) have suggested that a gene or genes regulating blood pressure may exist on rat chromosome 19 in the vicinity of the angiotensinogen gene. To test this hypothesis, we measured blood pressure in SHR progenitor and congenic strains that are genetically identical except for a segment of chromosome 19 containing the angiotensinogen gene transferred from the normotensive Brown Norway (BN) strain. Transfer of this segment of chromosome 19 from the BN strain onto the genetic background of the SHR induced significant decreases in systolic and diastolic blood pressures in the recipient SHR chromosome 19 congenic strain. To test for differences in angiotensinogen gene expression between the congenic and progenitor strains, we measured angiotensinogen mRNA levels in a variety of tissues, including aorta, brain, kidney, and liver. We found no differences between the progenitor and congenic strains in the angiotensinogen coding sequence or in angiotensinogen expression that would account for the blood pressure differences between the strains. In addition, no significant differences in plasma levels of angiotensinogen or plasma renin activity were detected between the 2 strains. Thus, transfer of a segment of chromosome 19 containing angiotensinogen from the BN rat into the SHR induces a decrease in blood pressure without inducing any major changes in plasma angiotensinogen levels or plasma renin activity. These results indicate that the differential chromosome segment trapped in the SHR chromosome 19 congenic strain contains a quantitative trait locus that influences blood pressure in the SHR but that this blood pressure effect is not explained by differences in plasma angiotensinogen levels or angiotensinogen expression.
Key Words: hypertension, experimental angiotensinogen genetics blood pressure rats
This article has been cited by other articles:
![]() |
M. D. Johnson, L. He, D. Herman, H. Wakimoto, C. A. Wallace, V. Zidek, P. Mlejnek, A. Musilova, M. Simakova, J. Vorlicek, et al. Dissection of Chromosome 18 Blood Pressure and Salt-Sensitivity Quantitative Trait Loci in the Spontaneously Hypertensive Rat Hypertension, September 1, 2009; 54(3): 639 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Deng Genetic basis of polygenic hypertension Hum. Mol. Genet., October 15, 2007; 16(R2): R195 - R202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Racasan, B. Braam, H. A. Koomans, and J. A. Joles Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon Am J Physiol Renal Physiol, April 1, 2005; 288(4): F626 - F636. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hinojos, E. Boerwinkle, M. Fornage, and P. A. Doris Combined Genealogical, Mapping, and Expression Approaches to Identify Spontaneously Hypertensive Rat Hypertension Candidate Genes Hypertension, April 1, 2005; 45(4): 698 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gardon, M. K Raizada, M. J Katovich, K. H Berecek, and C. H Gelband Gene therapy for hypertension and restenosis Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 211 - 216. [PDF] |
||||
![]() |
J. P. Rapp Genetic Analysis of Inherited Hypertension in the Rat Physiol Rev, January 1, 2000; 80(1): 135 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Dominiczak, D. C. Negrin, J. S. Clark, M. J. Brosnan, M. W. McBride, and M. Y. Alexander Genes and Hypertension : From Gene Mapping in Experimental Models to Vascular Gene Transfer Strategies Hypertension, January 1, 2000; 35(1): 164 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jeffs, C. D. Negrin, D. Graham, J. S. Clark, N. H. Anderson, D. Gauguier, and A. F. Dominiczak Applicability of a "Speed" Congenic Strategy to Dissect Blood Pressure Quantitative Trait Loci on Rat Chromosome 2 Hypertension, January 1, 2000; 35(1): 179 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Wright, D. T. O'Connor, E. Roberts, G. Kutey, C. C. Berry, L. U. Yoneda, D. Timberlake, and G. Schlager Genome Scan for Blood Pressure Loci in Mice Hypertension, October 1, 1999; 34(4): 625 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Corvol, A. Persu, A.-P. Gimenez-Roqueplo, and X. Jeunemaitre Seven Lessons From Two Candidate Genes in Human Essential Hypertension : Angiotensinogen and Epithelial Sodium Channel Hypertension, June 1, 1999; 33(6): 1324 - 1331. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |